Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,246,673 papers from all fields of science
Search
Sign In
Create Free Account
Gleason Pattern 5 (classification)
Known as:
Gleason Grade 5
, Gleason Pattern 5
A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Gleason Pattern 5 is a Possible Pathologic Predictor for Biochemical Recurrence after Laparoscopic Radical Prostatectomy
M. Ikeda
,
Noriyuki Amano
,
+6 authors
A. Irie
Asian Pacific Journal of Cancer Prevention
2019
Corpus ID: 85515301
Objective: Several prognostic factors for biochemical recurrence after radical prostatectomy have been reported, including…
Expand
2016
2016
Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation…
J. Vainshtein
,
M. Schipper
,
S. Vance
,
F. Feng
,
K. Olson
,
D. Hamstra
American Journal of Clinical Oncology
2016
Corpus ID: 32204316
Objectives:To assess the performance of the Cancer of the Prostate Risk Assessment (CAPRA) prognostic tool for freedom-from…
Expand
2016
2016
The natural history and clinical/molecular characterization of primary Gleason pattern 5 (G5) prostate cancer (PCa) treated with radical prostatectomy (RP).
J. C. Park
,
T. Lotan
,
A. Blackford
,
M. Carducci
,
S. Denmeade
,
M. Eisenberger
2016
Corpus ID: 81908602
e16576Background: Patients (pts) with primary G5 PCa have aggressive disease with high rates of recurrence and development of…
Expand
2014
2014
Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading…
R. Shah
,
Y. Tadros
Human Pathology
2014
Corpus ID: 5956776
Review
2011
Review
2011
Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy.
K. Hashine
,
Akihito Yuasa
,
Kensuke Shinomori
,
A. Shirato
,
I. Ninomiya
,
N. Teramoto
Japanese Journal of Clinical Oncology
2011
Corpus ID: 14051809
OBJECTIVES This study examined the rate of Gleason pattern 5 and the influence of tertiary Gleason pattern 5 on oncological…
Expand
2011
2011
The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse.
S. Halverson
,
M. Schipper
,
+6 authors
D. Hamstra
Radiotherapy and Oncology
2011
Corpus ID: 7730885
2010
2010
Prostate Cancer With Tertiary Gleason Pattern 5 in Prostate Needle Biopsy: Clinicopathologic Findings and Disease Progression
R. Dhir
2010
Corpus ID: 57107584
2009
2009
Accuracy of Modified Gleason Grading on Prostatic Biopsies
Weena Laddachayaporn
2009
Corpus ID: 70400713
Objective: The Modified Gleason Grading System was proposed by the 2005 International Society of Urological Pathology (ISUP…
Expand
Review
2007
Review
2007
The Prognostic Significance of Gleason Pattern 5 in Prostate Cancer Patients Treated With Pd-103 Brachytherapy
Hiroki Mitsuyama
,
K. Wallner
,
+4 authors
L. True
American Journal of Clinical Oncology
2007
Corpus ID: 21507754
Objective:To determine the effect of high-grade prostate cancer (Gleason pattern 5) on the prognosis of patients treated with Pd…
Expand
Review
2004
Review
2004
The Prognostic Significance of Gleason Pattern 5 in Prostate Cancer Patients Treated with Pd 103 plus Beam Radiation Therapy
T. Sherertz
,
K. Wallner
,
+4 authors
L. True
Cancer Journal
2004
Corpus ID: 23704677
BACKGROUNDThere is little clinical information specifically regarding the clinical significance of Gleason pattern 5 in prostate…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE